Invacare (NYSE:IVC) Given Daily News Impact Score of 0.13

Headlines about Invacare (NYSE:IVC) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research group identifies positive and negative press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Invacare earned a news impact score of 0.13 on Accern’s scale. Accern also gave media headlines about the health services provider an impact score of 45.5409912888904 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Several research analysts have recently issued reports on the stock. ValuEngine upgraded shares of Invacare from a “sell” rating to a “hold” rating in a report on Sunday, December 31st. KeyCorp restated a “buy” rating and set a $20.00 price objective on shares of Invacare in a report on Thursday, December 21st. Finally, Zacks Investment Research downgraded shares of Invacare from a “hold” rating to a “sell” rating in a report on Tuesday, November 14th. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the company’s stock. Invacare presently has a consensus rating of “Hold” and a consensus target price of $16.00.

Shares of Invacare (NYSE IVC) opened at $16.80 on Friday. The firm has a market cap of $530.86, a PE ratio of -7.18 and a beta of 2.45. Invacare has a 12-month low of $9.90 and a 12-month high of $17.95. The company has a current ratio of 2.28, a quick ratio of 1.57 and a debt-to-equity ratio of 0.55.

Invacare (NYSE:IVC) last released its quarterly earnings results on Tuesday, November 7th. The health services provider reported ($0.41) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.43) by $0.02. Invacare had a negative net margin of 7.95% and a negative return on equity of 13.33%. The firm had revenue of $250.91 million for the quarter, compared to analyst estimates of $239.88 million. During the same period in the previous year, the business earned ($0.37) earnings per share. The company’s revenue for the quarter was down 6.4% compared to the same quarter last year. analysts anticipate that Invacare will post -2.12 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, January 16th. Stockholders of record on Thursday, January 4th will be given a dividend of $0.0125 per share. The ex-dividend date is Wednesday, January 3rd. This represents a $0.05 dividend on an annualized basis and a dividend yield of 0.30%. Invacare’s payout ratio is -2.14%.

TRADEMARK VIOLATION NOTICE: This article was posted by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this article on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The original version of this article can be viewed at

About Invacare

Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company’s geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific.

Insider Buying and Selling by Quarter for Invacare (NYSE:IVC)

Receive News & Ratings for Invacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invacare and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply